TRCT
AHCO icon

Tower Research Capital (TRC)’s AdaptHealth AHCO Stock Holding History

Tower Research Capital (TRC)’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.6K Sell
3,897
-4,538
-54% -$50.7K ﹤0.01% 2912
2026
Q1 		$100K Sell
8,435
-17,804
-68% -$182K ﹤0.01% 2186
2025
Q4 		$261K Buy
26,239
+21,430
+446% +$205K 0.01% 1233
2025
Q3 		$43K Sell
4,809
-4,783
-50% -$44.3K ﹤0.01% 2642
2025
Q2 		$90.5K Buy
9,592
+7,297
+318% +$64.4K ﹤0.01% 2463
2025
Q1 		$24.9K Sell
2,295
-32,480
-93% -$327K ﹤0.01% 2770
2024
Q4 		$331K Buy
34,775
+34,209
+6,044% +$346K 0.01% 1329
2024
Q3 		$6.36K Sell
566
-19,341
-97% -$206K ﹤0.01% 4157
2024
Q2 		$199K Buy
19,907
+18,783
+1,671% +$191K ﹤0.01% 2080
2024
Q1 		$12.9K Sell
1,124
-25,660
-96% -$218K ﹤0.01% 3432
2023
Q4 		$195K Buy
26,784
+25,041
+1,437% +$197K ﹤0.01% 2112
2023
Q3 		$15.9K Sell
1,743
-1,400
-45% -$16.8K ﹤0.01% 3589
2023
Q2 		$38.3K Sell
3,143
-251
-7% -$2.8K ﹤0.01% 2810
2023
Q1 		$42K Buy
3,394
+2,916
+610% +$53.6K ﹤0.01% 2649
2022
Q4 		$9K Sell
478
-4,479
-90% -$94.7K ﹤0.01% 4152
2022
Q3 		$93K Buy
4,957
+1,630
+49% +$33.5K ﹤0.01% 2621
2022
Q2 		$60K Sell
3,327
-7,643
-70% -$124K ﹤0.01% 2710
2022
Q1 		$176K Buy
10,970
+7,345
+203% +$132K ﹤0.01% 1827
2021
Q4 		$89K Buy
3,625
+888
+32% +$20.8K ﹤0.01% 2307
2021
Q3 		$64K Buy
2,737
+108
+4% +$2.61K ﹤0.01% 2755
2021
Q2 		$72K Sell
2,629
-3,964
-60% -$113K ﹤0.01% 2697
2021
Q1 		$242K Buy
6,593
+5,388
+447% +$190K ﹤0.01% 1851
2020
Q4 		$45K Sell
1,205
-9,169
-88% -$284K ﹤0.01% 3206
2020
Q3 		$226K Buy
10,374
+9,979
+2,526% +$209K ﹤0.01% 2461
2020
Q2 		$6K Buy
+395
New +$6.6K ﹤0.01% 4193

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tower Research Capital (TRC)'s AHCO Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its AdaptHealth (AHCO) stake by 54% in Q2 2026, selling an estimated $50.7K and leaving 3,897 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2912.

Tower Research Capital (TRC) first reported a position in AHCO in Q2 2020 and has held it in 25 quarters since. The position peaked at $331K in Q4 2024. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Tower Research Capital (TRC) held 3,897 shares of AdaptHealth worth $40.6K as of Q2 2026.
  • Tower Research Capital (TRC) sold 4,538 AdaptHealth shares in Q2 2026, an estimated $50.7K.
  • AdaptHealth made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2912 holding.
  • Tower Research Capital (TRC) first reported a position in AdaptHealth in Q2 2020 and has held it in 25 quarters since.
  • Tower Research Capital (TRC)'s AdaptHealth position peaked at $331K in Q4 2024.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.